Skip to main content
SearchLoginLogin or Signup
Medical SciencesRR\C19
Published on Oct 08, 2020DOI

Reviews of "Impact of Glucocorticoids and Immunosuppressive Therapies on Symptomatic SARS-CoV-2 Infection in a Large Cohort of Patients with Chronic Inflammatory Arthritis"

Reviewers: Hector Chinoy, Alexander Oldroyd (The University of Manchester) | 📒📒📒◻️◻️ • Cristiana Santos (Complejo Asistencial Universitario de Leon) | 📗📗📗📗◻️

by Hector Chinoy, Alexander Oldroyd, and Cristiana Santos
Published onOct 08, 2020
Reviews of "Impact of Glucocorticoids and Immunosuppressive Therapies on Symptomatic SARS-CoV-2 Infection in a Large Cohort of Patients with Chronic Inflammatory Arthritis"
key-enterThis Pub is a Review of
Impact of Glucocorticoids and Immunosuppressive Therapies on Symptomatic SARS-CoV-2 Infection in a Large Cohort of Patients with Chronic Inflammatory Arthritis
by Favalli, Ennio, Bugatti, Serena, Klersy, Catherine, Biggioggero, Martina, Rossi, Silvia, De Lucia, Orazio, Bobbio-Pallavicini, Francesca, Murgo, Antonella, Balduzzi, Silvia, Caporali, Roberto, and Montecucco, Carlomaurizio
  • Published on Jun 26, 2020
  • papers.ssrn.com
Description

Background:  Prevalence and outcomes of Coronavirus Disease (COVID)-19 in relation to immunomodulatory medications are still unknown. The aim of the

To read the original manuscript, click the link above.

Summary of Reviews: This potentially informative article with some methodological flaws suggests that glucocorticoids are associated with increased COVID-19 risk among patients with chronic inflammatory arthritis. Patients treated with Disease-Modifying Drugs (DMARDS) were at reduced risk.

Reviewer 1 (Hector Chinoy, Alexander Oldroyd) | 📒📒📒◻️◻️

Reviewer 2 (Cristiana Santos) | 📗📗📗📗◻️

RR:C19 Strength of Evidence Scale Key

📕 ◻️◻️◻️◻️ = Misleading

📙📙 ◻️◻️◻️ = Not Informative

📒📒📒 ◻️◻️ = Potentially Informative

📗📗📗📗◻️ = Reliable

📘📘📘📘📘 = Strong

To read the reviews, click the links below.

Connections
1 of 2
A Supplement to this Pub
Review 1: "Impact of Glucocorticoids and Immunosuppressive Therapies on Symptomatic SARS-CoV-2 Infection in a Large Cohort of Patients with Chronic Inflammatory Arthritis"
Review 1: "Impact of Glucocorticoids and Immunosuppressive Therapies on Symptomatic SARS-CoV-2 Infection in a Large Cohort of Patients with Chronic Inflammatory Arthritis"
by Hector Chinoy and Alexander Oldroyd
  • Published on Oct 08, 2020
  • rrid.mitpress.mit.edu
Description

This potentially informative article with some methodological flaws suggests that glucocorticoids are associated with increased COVID-19 risk among patients with chronic inflammatory arthritis. Patients treated with Disease-Modifying Drugs (DMARDS) were at reduced risk.

A Supplement to this Pub
Review 2: "Impact of Glucocorticoids and Immunosuppressive Therapies on Symptomatic SARS-CoV-2 Infection in a Large Cohort of Patients with Chronic Inflammatory Arthritis"
Review 2: "Impact of Glucocorticoids and Immunosuppressive Therapies on Symptomatic SARS-CoV-2 Infection in a Large Cohort of Patients with Chronic Inflammatory Arthritis"
by Cristiana Santos
  • Published on Oct 08, 2020
  • rrid.mitpress.mit.edu
Description

This potentially informative article with some methodological flaws suggests that glucocorticoids are associated with increased COVID-19 risk among patients with chronic inflammatory arthritis. Patients treated with Disease-Modifying Drugs (DMARDS) were at reduced risk.

License
Creative Commons Attribution 4.0 International License (CC-BY 4.0)
Comments
1
?
Login to discuss
Vape Factory:
Rapid Reviews Infectious Diseases
Rapid Reviews Infectious Diseases
Published with